dPCR and qPCR Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

dPCR and qPCR Market to 2025- Global Analysis and Forecasts by Technology (Digital PCR (dPCR) and Quantitative PCR (qPCR)); Product (Reagents & Consumables, Instruments, and Software and Services); Application (Clinical Application, Research Application, and Forensic Application) and Geography

Publication Month: Nov 2018 | Report Code: TIPHE100000817 | No. of Pages: 159 | Category: Biotechnology | Status: Published

The global dPCR and qPCR market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 Mn in 2017. The market is estimated to grow with a CAGR of 9.1% from 2018-2025.

dPCR and qPCR market is segmented by technology, product and application. Global dPCR and qPCR market, based on technology was segmented into digital PCR (dPCR) and quantitative PCR (qPCR). Global dPCR and qPCR market, based on the product was segmented into reagents & consumables, instruments, and software and services. The dPCR and qPCR market, based on application was segmented into clinical applications, research applications, and forensic applications.


dPCR and qPCR are  PCR technologies which have evolved over the years from thermostable polymerases, development of automated thermocyclers to latest digital PCR (d-PCR) methodologies. dPCR and qPCR have been extensively used in molecular diagnostics and therefore have enabled detection of various diseases. The report would be of an interest to various stakeholders operating in the dPCR and qPCR market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

The objective of the study is to describe, define, and forecast the dPCR and qPCR market by technology, product & services, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The report analyzes factors affecting dPCR and qPCR market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key dPCR and qPCR manufacturing companies along with their SWOT analysis and market strategies.

The prominent players operating in the market of dPCR and qPCR across the globe includes Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, TaKARA BIO, INC, Agilent Technologies, Inc., bioMérieux SA, Danaher, and Fluidigm Corporation among others. For instance, in July 2017 Agilent Technologies Inc. expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic use. And the launch expanded the business of the company in global dPCR and qPCR market.

TABLE OF CONTENTS

1. INTRODUCTION 21
1.1 SCOPE OF THE STUDY 21
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 21

2. GLOBAL DPCR AND QPCR MARKET – KEY TAKEAWAYS 22

3. GLOBAL DPCR AND QPCR MARKET – MARKET LANDSCAPE 25
3.1 OVERVIEW 25
3.2 MARKET SEGMENTATION 25
3.2.1 Global dPCR and qPCR market – By Technology 26
3.2.2 Global dPCR and qPCR market – By Product 26
3.2.3 Global dPCR and qPCR market – By Application 26
3.2.4 Global dPCR and qPCR market – By Geography 26
3.4 PEST ANALYSIS 28
3.4.1 North America – PEST Analysis 28
3.4.2 Europe– PEST Analysis 30
3.4.3 Asia Pacific – PEST Analysis 32
3.4.4 Middle East & Africa – PEST Analysis 34
3.4.5 South & Central America – PEST Analysis 36

4. GLOBAL DPCR AND QPCR MARKET – KEY MARKET DYNAMICS 38
4.1 KEY MARKET DRIVERS 38
4.1.1 Increasing Incidence of Genetic Diseases 38
4.1.2 Increase in Investments & Funds for Gene Synthesis 38
4.1.3 Technological Advancements in PCR Technologies 39
4.2 KEY MARKET RESTRAINTS 40
4.2.1 High Costs of PCR Systems 40
4.2.2 Technical Limitations Associated with qPCR 40
4.3 KEY MARKET OPPORTUNITIES 41
4.3.1 Growing adoption of PCR methods in Emerging countries 41
4.4 FUTURE TRENDS 41
4.4.1 Development of Droplet Digital PCR (ddPCR). 41
4.5 IMPACT ANALYSIS 42

5. DPCR AND QPCR MARKET – GLOBAL ANALYSIS 43
5.1 GLOBAL DPCR AND QPCR MARKET REVENUE FORECASTS AND ANALYSIS 43
5.2 GLOBAL DPCR AND QPCR MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 44
5.3 MARKET POSITIONING 45
5.4 PERFORMANCE OF KEY PLAYERS 45
5.4.1 Thermo Fisher Scientific, Inc. 45
5.4.2 F. Hoffmann-La Roche Ltd 45
5.5 EXPERT OPINIONS 46

6. GLOBAL DPCR AND QPCR MARKET ANALYSIS – BY TECHNOLOGY 47
6.1 OVERVIEW 47
6.2 DIGITAL PCR (DPCR) MARKET 48
6.2.1 Overview 48
6.2.2 Global Digital PCR (dPCR) Market Revenue and Forecasts to 2025 (US$ Mn) 48
6.3 QUANTITATIVE PCR (QPCR) MARKET 49
6.3.1 Overview 49
6.3.2 Global Quantitative PCR (qPCR) Market Revenue and Forecasts to 2025 (US$ Mn) 49

7. GLOBAL DPCR AND QPCR MARKET ANALYSIS – BY PRODUCT 50
7.1 OVERVIEW 50
7.2 REAGENTS & CONSUMABLES MARKET 50
7.2.1 Overview 50
7.2.2 Global Reagents and Consumables Market Revenue and Forecasts to 2025 (US$ Mn) 51
7.3 INSTRUMENTS MARKET 52
7.3.1 Overview 52
7.3.2 Global Instruments Market Revenue and Forecasts to 2025 (US$ Mn) 52
7.4 SOFTWARE & SERVICES MARKET 53
7.4.1 Overview 53
7.4.2 Global Software & Services Market Revenue and Forecasts to 2025 (US$ Mn) 53

8. GLOBAL DPCR AND QPCR MARKET ANALYSIS– BY APPLICATION 54
8.1 OVERVIEW 54
8.2 GLOBAL DPCR AND QPCR MARKET, BY APPLICATION 2017 & 2025 (%) 54
8.2.1 Clinical Application Market 54
8.2.1.1 Overview 54
8.2.1.2 Global Clinical Application Market Revenue And Forecasts To 2025 (US$ Mn) 54
8.2.1.3 Pathogen Testing Market 56
8.2.1.3.1 Overview 56
8.2.1.3.2 Global Pathogen Testing Market Revenue And Forecasts To 2025 (US$ Mn) 56
8.2.1.4 Oncology Testing Market 57
8.2.1.4.1 Overview 57
8.2.1.4.2 Global Oncology Testing Market Revenue And Forecasts To 2025 (US$ Mn) 57
8.2.1.5 Blood Screening Testing Market 57
8.2.1.5.1 Overview 57
8.2.1.5.2 Global Blood Screening Testing Market Revenue And Forecasts To 2025 (US$ Mn) 58
8.2.2 Research Application Market 58
8.2.2.1 Overview 58
8.2.2.2 Global Research Application Market Revenue And Forecasts To 2025 (US$ Mn) 58
8.2.3 Forensic Application Market 59
8.2.3.1 Overview 59
8.2.3.2 Global Forensic Application Market Revenue And Forecasts To 2025 (US$ Mn) 59

9. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 61
9.1 OVERVIEW 61
9.2 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
9.3 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 62
9.3.1 North America dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 62
9.3.2 North america dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 62
9.3.3 North america Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 63
9.4 NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 63
9.5 US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
9.5.1 US dPCR and qPCR Market Revenue and Forecasts to 2025 (US$ Mn) 65
9.5.2 US dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 65
9.5.3 US dPCR and qPCR market Revenue And Forecasts to 2025, By Product (US$ Mn) 65
9.5.4 US dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 66
9.5.5 US Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 66
9.6 CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
9.6.1 Canada dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 67
9.6.2 Canada dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 68
9.6.3 Canada dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 68
9.6.4 Canada dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 68
9.6.5 Canada Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 69
9.7 MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.7.1 Mexico DPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 70
9.7.2 Mexico dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 71
9.7.3 Mexico dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 71
9.7.4 Mexico dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 71
9.7.5 Mexico Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 72

10. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 73
10.1 OVERVIEW 73
10.2 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
10.3 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 74
10.3.1 Europe dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 74
10.3.2 Europe dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 74
10.3.3 Europe Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 75
10.4 EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 75
10.5 UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
10.5.1 UK dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 77
10.5.2 UK dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 77
10.5.3 UK dPCR and qPCR market Revenue And Forecasts to 2025, By Product (US$ Mn) 77
10.5.4 UK dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 78
10.5.5 UK Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 78
10.6 GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
10.6.1 Germany dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 80
10.6.2 Germany dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 80
10.6.3 Germany dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 80
10.6.4 Germany dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 81
10.6.5 Germany Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 81
10.7 FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
10.7.1 France dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 83
10.7.2 France dPCR and qPCR Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 83
10.7.3 France dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 83
10.7.4 France dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84
10.7.5 France Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 84

11. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 85
11.1 OVERVIEW 85
11.2 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
11.3 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 86
11.3.1 Asia Pacific dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 86
11.3.2 Asia Pacific dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86
11.3.3 Asia Pacific Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 87
11.4 ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 87
11.5 CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
11.5.1 China dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 88
11.6 CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 88
11.6.1 China dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 89
11.6.2 China dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 89
11.6.3 China Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 89
11.7 JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
11.7.1 Japan dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 90
11.8 JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 90
11.8.1 Japan dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 90
11.8.2 Japan dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 91
11.8.3 Japan Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 91
11.9 INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
11.9.1 India dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 92
11.10 INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 92
11.10.1 India dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 93
11.10.2 India dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 93
11.10.3 India Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 93

12. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 94
12.1 OVERVIEW 94
12.2 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 95
12.3 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 95
12.3.1 Middle East and Africa dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 95
12.3.2 Middle East and Africa dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 96
12.3.3 Middle East and Africa Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 96
12.4 MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 96
12.6 UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 98
12.6.1 UAE dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 98
12.7 UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 98
12.7.1 UAE dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 99
12.7.2 UAE dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 99
12.7.3 UAE Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 99
12.8 SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
12.8.1 Saudi Arabia dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 100
12.9 SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 100
12.9.1 Saudi Arabia dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 101
12.9.2 Saudi Arabia dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 101
12.9.3 Saudi Arabia Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 101
12.10 SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
12.10.1 South Africa dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 102
12.11 SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 102
12.11.1 South Africa dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 103
12.11.2 South Africa dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 103
12.11.3 South Africa Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 103

13. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 104
13.1 OVERVIEW 104
13.2 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
13.3 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 105
13.3.1 South and Central America dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 105
13.3.2 South and Central America dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 106
13.3.3 South and Central America Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 106
13.4 SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 106
13.5 BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 107
13.5.1 Brazil dPCR and qPCR market Revenue and Forecasts to 2025 (US$ Mn) 107
13.6 BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS, BY TECHNOLOGY (US$ MN) 107
13.6.1 Brazil dPCR and qPCR Market Revenue And Forecasts to 2025, By Product (US$ Mn) 108
13.6.2 Brazil dPCR and qPCR Market Revenue And Forecasts to 2025, By Application (US$ Mn) 108
13.6.3 Brazil Clinical Application Market Revenue And Forecasts to 2025, By Type (US$ Mn) 108

14. DPCR AND QPCR MARKET –KEY COMPANY PROFILES 110
14.1 ABBOTT 110
14.1.1 Key Facts 110
14.1.2 Business Description 110
14.1.3 Financial Information 111
14.1.4 Product Portfolio 111
14.1.5 SWOT Analysis 111
14.1.6 Key Developments 113
14.2 F. HOFFMANN-LA ROCHE LTD. 114
14.2.1 Key Facts 114
14.2.2 Business Description 114
14.2.3 Financial Overview 115
14.2.4 Product Portfolio 115
14.2.5 Swot Analysis 116
14.2.6 Key Developments 117
14.3 THERMO FISHER SCIENTIFIC, INC. 118
14.3.1 Key Facts 118
14.3.2 Business Description 118
14.3.3 Financial Information 119
14.3.4 Product Portfolio 119
14.3.5 SWOT Analysis 120
14.3.6 Key Developments 121
14.4 BIO-RAD LABORATORIES, INC. 122
14.4.1 Key Facts 122
14.4.2 Business Description 122
14.4.3 Financial Information 123
14.4.4 Product Portfolio 123
14.4.5 SWOT Analysis 123
14.4.6 Key Developments 124
14.5 QIAGEN 126
14.5.1 Key Facts 126
14.5.2 Business Description 126
14.5.3 Financial Overview 126
14.5.4 Product Portfolio 127
14.5.5 Swot Analysis 128
14.5.6 Key Developments 129
14.6 TAKARA BIO, INC. 130
14.6.1 Key Facts 130
14.6.2 Business Description 130
14.6.3 Financial Information 131
14.6.4 Product Portfolio 131
14.6.5 SWOT Analysis 132
14.6.6 Key Developments 133
14.7 AGILENT TECHNOLOGIES, INC. 135
14.7.1 Key Facts 135
14.7.2 Business Description 135
14.7.3 Financial Information 136
14.7.4 Product Portfolio 136
14.7.5 SWOT Analysis 137
14.7.6 Key Developments 138
14.8 BIOMÉRIEUX SA 139
14.8.1 Key Facts 139
14.8.2 Business Description 139
14.8.3 Financial Information 140
14.8.4 Product Portfolio 140
14.8.5 SWOT Analysis 141
14.8.6 Key Developments 142
14.9 DANAHER 143
14.9.1 Key Facts 143
14.9.2 Business Description 143
14.9.3 Financial Overview 143
14.9.4 Product Portfolio 144
14.9.5 Swot Analysis 144
14.9.6 Key Developments 146
14.10 FLUIDIGM CORPORATION 147
14.10.1 Key Facts 147
14.10.2 Business Description 147
14.10.3 Financial Overview 148
14.10.4 Product Portfolio 148
14.10.5 Swot Analysis 149
14.10.6 Key Developments 150

15. APPENDIX 152
15.1 ABOUT THE INSIGHT PARTNERS 152
15.2 GLOSSARY OF TERMS 153
15.3 METHODOLOGY 156
15.3.1 Coverage 157
15.3.2 Secondary Research 158
15.3.3 Primary Research 158

LIST OF TABLES

TABLE 1. NORTH AMERICA AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 63
TABLE 2. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 63
TABLE 3. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64
TABLE 4. NORTH AMERICA AND AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 64
TABLE 5. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66
TABLE 6. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 66
TABLE 7. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 67
TABLE 8. US CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 67
TABLE 9. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 69
TABLE 10. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 69
TABLE 11. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
TABLE 12. CANADA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 70
TABLE 13. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 72
TABLE 14. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 72
TABLE 15. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 72
TABLE 16. MEXICO CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 73
TABLE 17. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 75
TABLE 18. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 75
TABLE 19. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
TABLE 20. EUROPE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 76
TABLE 21. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 78
TABLE 22. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 78
TABLE 23. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
TABLE 24. UK CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 79
TABLE 25. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 81
TABLE 26. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 81
TABLE 27. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 82
TABLE 28. GERMANY CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 82
TABLE 29. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 84
TABLE 30. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 84
TABLE 31. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 85
TABLE 32. FRANCE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 85
TABLE 33. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 87
TABLE 34. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
TABLE 35. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
TABLE 36. ASIA PACIFIC CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 88
TABLE 37. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 89
TABLE 38. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90
TABLE 39. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 90
TABLE 40. CHINA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 90
TABLE 41. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 91
TABLE 42. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 92
TABLE 43. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
TABLE 44. JAPAN CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 92
TABLE 45. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 93
TABLE 46. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 94
TABLE 47. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 94
TABLE 48. INDIA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 94
TABLE 49. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 96
TABLE 50. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
TABLE 51. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 52. MIDDLE EAST AND AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 97
TABLE 53. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 99
TABLE 54. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 100
TABLE 55. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
TABLE 56. UAE CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 100
TABLE 57. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 101
TABLE 58. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 102
TABLE 59. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 102
TABLE 60. SAUDI ARABIA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 102
TABLE 61. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 103
TABLE 62. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 104
TABLE 63. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
TABLE 64. SOUTH AFRICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 104
TABLE 65. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 106
TABLE 66. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 106
TABLE 67. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107
TABLE 68. SOUTH AND CENTRAL AMERICA CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 107
TABLE 69. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 109
TABLE 70. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 109
TABLE 71. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 109
TABLE 72. BRAZIL CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 109
TABLE 73. GLOSSARY OF TERMS, DPCR AND QPCR MARKET 154

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC DPCR AND QPCR MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 23
FIGURE 2. GLOBAL DPCR AND QPCR MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 24
FIGURE 3. GLOBAL DPCR AND QPCR MARKET BY APPLICATION, MARKET SHARE (%), 2017 24
FIGURE 4. GLOBAL DPCR AND QPCR MARKET BY APPLICATION, MARKET SHARE (%), 2017 24
FIGURE 5. DPCR AND QPCR MARKET SEGMENTATION 26
FIGURE 6. DPCR AND QPCR SEGMENTATION, BY REGION 27
FIGURE 7. NORTH AMERICA PEST ANALYSIS 29
FIGURE 8. EUROPE PEST ANALYSIS 31
FIGURE 9. ASIA PACIFIC PEST ANALYSIS 33
FIGURE 10. MIDDLE EAST & AFRICA PEST ANALYSIS 35
FIGURE 11. SOUTH & CENTRAL AMERICA PEST ANALYSIS 37
FIGURE 12. DPCR AND QPCR MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 43
FIGURE 13. GLOBAL DPCR AND QPCR MARKET – REVENUE FORECASTS AND ANALYSIS – 2016- 2025 44
FIGURE 14. GLOBAL DPCR AND QPCR MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 45
FIGURE 15. GLOBAL DPCR AND QPCR MARKET – MARKET POSITIONING, 2017 46
FIGURE 16. GLOBAL DPCR AND QPCR MARKET BREAKDOWN BY TECHNOLOGY, 2017 & 2025 (%) 48
FIGURE 17. GLOBAL DIGITAL PCR (DPCR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
FIGURE 18. GLOBAL QUANTITATIVE PCR (QPCR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 19. GLOBAL DPCR AND QPCR MARKET BREAKDOWN BY PRODUCT, 2017 & 2025 (%) 51
FIGURE 20. GLOBAL REAGENTS AND CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 21. GLOBAL INSTRUMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 22. GLOBAL SOFTWARE & SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 23. GLOBAL DPCR AND QPCR MARKET, BY APPLICATION 2017 & 2025 (%) 55
FIGURE 24. GLOBAL CLINICAL APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 25. GLOBAL PATHOGEN TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 26. GLOBAL ONCOLOGY TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 27. GLOBAL BLOOD SCREENING TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 28. GLOBAL RESEARCH APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 29. GLOBAL FORENSIC APPLICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
FIGURE 30. NORTH AMERICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 62
FIGURE 31. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
FIGURE 32. NORTH AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 64
FIGURE 33. US DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
FIGURE 34. CANADA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 35. MEXICO DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
FIGURE 36. EUROPE DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 74
FIGURE 37. EUROPE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
FIGURE 38. EUROPE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 76
FIGURE 39. UK DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 40. GERMANY DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
FIGURE 41. FRANCE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
FIGURE 42. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 86
FIGURE 43. ASIA PACIFIC MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
FIGURE 44. ASIA PACIFIC DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 88
FIGURE 45. CHINA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
FIGURE 46. JAPAN DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
FIGURE 47. INDIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93
FIGURE 48. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 95
FIGURE 49. MIDDLE EAST AND AFRICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 50. MIDDLE EAST AND AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 97
FIGURE 51. UAE DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
FIGURE 52. SAUDI ARABIA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
FIGURE 53. SOUTH AFRICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
FIGURE 54. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 105
FIGURE 55. SOUTH AND CENTRAL AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106
FIGURE 56. SOUTH AND CENTRAL AMERICA DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 107
FIGURE 57. BRAZIL DPCR AND QPCR MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 108

The List of Companies

1. Abbott
2. F. Hoffmann-La Roche Ltd.
3. Thermo Fisher Scientific Inc.
4. Bio-Rad Laboratories, Inc.
5. QIAGEN
6. TaKARA BIO, INC
7. Agilent Technologies, Inc.
8. bioMérieux SA
9. Danaher
10. Fluidigm Corporation

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the dPCR and qPCR market.

-Highlights key business priorities in order to assist companies to realign their business strategies.

-The key findings and recommendations highlight crucial progressive industry trends in the global dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.

-Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

-Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

-Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Select License Type
USD $3000
USD $4550
USD $6550
USD $8550